PIK3CA Mutations Are Associated With Decreased Benefit to...

Journal of Clinical Oncology 2015 / 04 Vol. 33; Iss. 12

PIK3CA Mutations Are Associated With Decreased Benefit to Neoadjuvant Human Epidermal Growth Factor Receptor 2-Targeted Therapies in Breast Cancer

Majewski, I. J., Nuciforo, P., Mittempergher, L., Bosma, A. J., Eidtmann, H., Holmes, E., Sotiriou, C., Fumagalli, D., Jimenez, J., Aura, C., Prudkin, L., Diaz-Delgado, M. C., de la Pena, L., Loi, S.,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
33
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/jco.2014.55.2158
Date:
April, 2015
File:
PDF, 216 KB
english, 2015
Conversion to is in progress
Conversion to is failed